PLAU and nonpapillary renal cell carcinoma: The HR of 9.83 (P = 0.032) obtained for patients with high levels of uPA and/or uPAR in multivariate analysis in the pT1+2 subgroup further emphasises the potential prognostic utility of uPA and uPAR protein expression for patients with ccRCC.